Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent...

Area of Science:

• Psychiatry
• Clinical Psychology
• Medical Research

Background:

• Two-thirds of major depressive disorder (MDD) patients present with somatic symptoms.
• No prior studies have subtyped MDD based on somatic symptom profiles.
• This study addresses the gap by classifying MDD via somatic symptoms and tracking subtype prognosis.

Purpose of the Study:

• To classify major depressive disorder (MDD) into subtypes based on somatic symptom presentation.
• To investigate the longitudinal prognosis of each identified MDD subtype.
• To determine if somatic symptom severity correlates with treatment outcomes.

Main Methods:

• Latent profile analysis (LPA) was used on somatic symptom data from the Algorithm Guided Treatment Strategies for Major Depressive Disorder (AGTs-MDD) study.
• Generalized linear mixed models (GLMM) analyzed the longitudinal prognosis of LPA-defined subtypes.
• Primary outcome measures included Hamilton Depression Rating Scale (HAMD) scores, reduction rates, and depression and somatic symptom scale (DSSS) scores.

Main Results:

• Three MDD subtypes were identified: mild (68.9%), moderate (19.2%), and severe (11.9%) somatic symptoms.
• Significant differences in HAMD, somatic, and depressive DSSS scores were observed across subtypes over 12 weeks.
• The moderate somatic symptom group showed higher HAMD scores and lower reduction rates at week 6, with more severe depressive symptoms at weeks 4 and 6.

Conclusions:

• Somatic symptoms are a crucial factor in MDD patient presentation and prognosis.
• Patients with moderate somatic symptoms warrant increased clinical attention due to potential for poorer outcomes.
• Subtyping MDD by somatic symptoms offers a novel approach to understanding disease heterogeneity and guiding treatment.